Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1372.7000 22.20 (1.64%)
NSE Sep 26, 2025 14:51 PM
Volume: 256.1K
 

logo
Ipca Laboratories Ltd.
14 Oct 2024
1372.70
1.64%
buy
by Motilal Oswal
Target: 1950 | Upside : 42.1%
Motilal Oswal
After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.
 
Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended
Market trades lower, SC defers Vodafone Idea's AGR dues plea hearing
Trendlyne Marketwatch | 26 Sep 2025, 02:44PM
Indices at a glance: Biggest winners and losers over the past year
The Baseline | 25 Sep 2025, 12:17PM
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021